Abstract
We analyzed the clinicopathological characteristics of 1,425 primary breast cancer patients admitted to the Cancer Hospital of Shantou University Medical College from 1995 to 2008. The peak age group was 45-49 years old and median age was 49 years old. Sixty-two percent of the patients were pre-menopausal, while the remaining was postmenopausal. In the present study, 53% of the patients were in stage I-II of TNM staging. Immunohistochemical detection demonstrated that estrogen receptor (ER), progestrone receptor (PR) and human epidermal growth factor receptor 2 (Her-2) were 59%, 56% and 32% positive, respectively. The most common histological type was invasive ductal carcinoma accounting for 76% of total patients. Most patients received surgical treatment (97.2%) and chemotherapy (74.4%). The overall five-year and ten-year survival rates were 63% and 56% respectively. Multivariate analyses revealed that the tumor size, axillary lymph node involvement, and clinical staging were independent risk factors for overall survival (OS). In summary, the largest cohort of breast cancer patients in Eastern Guangdong was analyzed with their clinicopathological characteristics. We demonstrated that the similar clinical outcomes were obtained by multi-modality therapy, and the tumor size and lymph node involvement are the independent prognostic factors being same as the previous reports.
Keywords: Breast cancer, clinicopathological characteristics, lymph node involvement, overall survival, prognosis, tumor size.
Current Signal Transduction Therapy
Title:Analysis of Clinicopathological Characteristics and Prognosis of 1425 Primary Breast Cancer Patients in Eastern Guangdong, China
Volume: 9 Issue: 1
Author(s): Wen-He Huang, Si-Qi Qiu, Jun-Dong Wu, Cai-Wen Du, Yu-Kun Cui and Guo-Jun Zhang
Affiliation:
Keywords: Breast cancer, clinicopathological characteristics, lymph node involvement, overall survival, prognosis, tumor size.
Abstract: We analyzed the clinicopathological characteristics of 1,425 primary breast cancer patients admitted to the Cancer Hospital of Shantou University Medical College from 1995 to 2008. The peak age group was 45-49 years old and median age was 49 years old. Sixty-two percent of the patients were pre-menopausal, while the remaining was postmenopausal. In the present study, 53% of the patients were in stage I-II of TNM staging. Immunohistochemical detection demonstrated that estrogen receptor (ER), progestrone receptor (PR) and human epidermal growth factor receptor 2 (Her-2) were 59%, 56% and 32% positive, respectively. The most common histological type was invasive ductal carcinoma accounting for 76% of total patients. Most patients received surgical treatment (97.2%) and chemotherapy (74.4%). The overall five-year and ten-year survival rates were 63% and 56% respectively. Multivariate analyses revealed that the tumor size, axillary lymph node involvement, and clinical staging were independent risk factors for overall survival (OS). In summary, the largest cohort of breast cancer patients in Eastern Guangdong was analyzed with their clinicopathological characteristics. We demonstrated that the similar clinical outcomes were obtained by multi-modality therapy, and the tumor size and lymph node involvement are the independent prognostic factors being same as the previous reports.
Export Options
About this article
Cite this article as:
Huang Wen-He, Qiu Si-Qi, Wu Jun-Dong, Du Cai-Wen, Cui Yu-Kun and Zhang Guo-Jun, Analysis of Clinicopathological Characteristics and Prognosis of 1425 Primary Breast Cancer Patients in Eastern Guangdong, China, Current Signal Transduction Therapy 2014; 9 (1) . https://dx.doi.org/10.2174/1574362409666140724183612
DOI https://dx.doi.org/10.2174/1574362409666140724183612 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Foxp3 in Regulatory T Cell Differentiation and Function
Current Immunology Reviews (Discontinued) Targeting Nanoparticles as Drug Delivery Systems for Cancer Treatment
Current Nanoscience From ImmunoToxins to ImmunoRNases
Current Pharmaceutical Biotechnology Active Targeting Strategies for Anticancer Drug Nanocarriers
Current Drug Delivery MUC1 Story: Great Expectations, Disappointments and the Renaissance
Current Medicinal Chemistry Pharmaceutical Applications of Graphene-based Nanosheets
Current Pharmaceutical Biotechnology Molecular Imaging of Breast Cancer: Role of RGD Peptides
Mini-Reviews in Medicinal Chemistry In Vivo Biological Evaluation of Ethyl 4-(7-hydroxy-4-methyl-2-oxoquinolin-1- ylamino)-coumarin-3-carboxylate as an Antitumor Agent
Anti-Cancer Agents in Medicinal Chemistry Can Untargeted Metabolomics Be Utilized in Drug Discovery/Development?
Current Topics in Medicinal Chemistry Chitosan Nanoparticles: An Approbative System for the Delivery of Herbal Bioactives
The Natural Products Journal Ethanol Extract of Achillea fragrantissima Enhances Angiogenesis through Stimulation of VEGF Production
Endocrine, Metabolic & Immune Disorders - Drug Targets BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds
Current Cancer Drug Targets Peptide-Receptor Ligands and Multivalent Approach
Anti-Cancer Agents in Medicinal Chemistry FOXM1-Dependent Transcriptional Regulation of EZH2 Induces Proliferation and Progression in Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Atomic Force Microscopy and Anodic Porous Allumina of Nucleic Acid Programmable Protein Arrays
Recent Patents on Biotechnology The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders
Current Pharmaceutical Design Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry Ghrelin and Motilin in the Gastrointestinal System
Current Pharmaceutical Design Promoter Structure and Transcriptional Regulation of Human β-Galactoside α2, 3-Sialyltransferase Genes
Current Drug Targets Antiangiogenic Drugs and Tyrosine Kinases
Anti-Cancer Agents in Medicinal Chemistry